Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: Hospira

..

Manufacturer: Hospira (Shop the Brand)

Lidocaine HCl 2%and Epinephrine Injection 20 mg/mL, Fliptop Multiple Dose Vial 30 mL, Each

Item Code: 000719
Mfg Part #: 0409-3182-02
$12.99
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Lidocaine Hydrochloride and Epinephrine Injection


Lidocaine Hydrochloride and Epinephrine Injection is a combination of lidocaine, an amide local anesthetic, and epinephrine, an alpha and beta adrenergic agonist. It is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and obstetrical procedures.

Key Benefits:
• Indicated for a broad range of anesthetic procedures including infiltration, peripheral nerve blocks, sympathetic nerve blocks, epidural, and caudal anesthesia
• Available in multiple concentrations (0.5%, 1%, 1.5%, 2%) and presentations including single-dose ampuls, single-dose vials, and multiple-dose vials to support diverse clinical needs
• Epinephrine component allows higher maximum recommended dose (up to 7 mg/kg, not to exceed 500 mg) compared to lidocaine used without epinephrine (4.5 mg/kg, not to exceed 300 mg)
• Approved for use in both adult and pediatric patients across a wide range of procedures
• 1.5% concentration with 1:200,000 epinephrine formulation is specifically recommended as a test dose for epidural and caudal blocks to help detect unintended intravascular or intrathecal injection

Dosage & Administration:
The dosage varies with the anesthetic procedure, area to be anesthetized, vascularity of tissues, depth of anesthesia required, and physical condition of the patient. For normal healthy adults, the maximum recommended dose of Lidocaine Hydrochloride and Epinephrine Injection should not exceed 7 mg/kg body weight and generally should not exceed 500 mg total. For continuous epidural or caudal anesthesia, the maximum recommended dosage should not be administered at intervals of less than 90 minutes. Pediatric dosing is weight- and age-based; for children over 3 years, dosing should not exceed approximately 3.3 mg/kg to 4.4 mg/kg depending on weight and development. The lowest effective concentration and smallest dose producing the desired result should always be used.

Why Choose Lidocaine Hydrochloride and Epinephrine Injection?
This combination product provides both local anesthetic action through lidocaine and vasoconstrictive support through epinephrine, enabling use across a broad spectrum of anesthetic block types — including infiltration, nerve block, epidural, and caudal — in a single formulation available in multiple concentrations and vial presentations, as described in the prescribing information.

Warnings:
• Dose-related toxicity: Cardiovascular and respiratory vital signs and patient's state of consciousness must be monitored after injection; delays in managing toxicity may lead to acidosis, cardiac arrest, and death
• Methemoglobinemia: Cases have been reported with local anesthetic use, with potentially severe consequences including seizures, coma, arrhythmias, and death; patients with glucose-6-phosphate dehydrogenase deficiency, infants under 6 months, and those on oxidizing agents are at increased risk
• Risk of systemic toxicities with unintended intravascular or intrathecal injection: May result in CNS or cardiorespiratory depression, coma, and respiratory arrest; aspirate for blood or cerebrospinal fluid prior to each injection and use a test dose for epidural blocks when feasible

Disclaimer: This product description was generated by AI and is for informational purposes only. Please refer to the latest package insert for complete information on indications,
contraindications, warnings, and proper use.

Products specifications
Manufacturer: Hospira (Shop the Brand)

Lidocaine HCl 2%and Epinephrine Injection 20 mg/mL, Fliptop Multiple Dose Vial 30 mL, 25/Tray

Item Code: 009514
Mfg Part #: 0409-3182-02
$292.28
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Lidocaine Hydrochloride and Epinephrine Injection


Lidocaine Hydrochloride and Epinephrine Injection is a combination of lidocaine, an amide local anesthetic, and epinephrine, an alpha and beta adrenergic agonist. It is indicated in adult and pediatric patients for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and obstetrical procedures.

Key Benefits:
• Indicated for a broad range of anesthetic procedures including infiltration, peripheral nerve blocks, sympathetic nerve blocks, epidural, and caudal anesthesia
• Available in multiple concentrations (0.5%, 1%, 1.5%, 2%) and presentations including single-dose ampuls, single-dose vials, and multiple-dose vials to support diverse clinical needs
• Epinephrine component allows higher maximum recommended dose (up to 7 mg/kg, not to exceed 500 mg) compared to lidocaine used without epinephrine (4.5 mg/kg, not to exceed 300 mg)
• Approved for use in both adult and pediatric patients across a wide range of procedures
• 1.5% concentration with 1:200,000 epinephrine formulation is specifically recommended as a test dose for epidural and caudal blocks to help detect unintended intravascular or intrathecal injection

Dosage & Administration:
The dosage varies with the anesthetic procedure, area to be anesthetized, vascularity of tissues, depth of anesthesia required, and physical condition of the patient. For normal healthy adults, the maximum recommended dose of Lidocaine Hydrochloride and Epinephrine Injection should not exceed 7 mg/kg body weight and generally should not exceed 500 mg total. For continuous epidural or caudal anesthesia, the maximum recommended dosage should not be administered at intervals of less than 90 minutes. Pediatric dosing is weight- and age-based; for children over 3 years, dosing should not exceed approximately 3.3 mg/kg to 4.4 mg/kg depending on weight and development. The lowest effective concentration and smallest dose producing the desired result should always be used.

Why Choose Lidocaine Hydrochloride and Epinephrine Injection?
This combination product provides both local anesthetic action through lidocaine and vasoconstrictive support through epinephrine, enabling use across a broad spectrum of anesthetic block types — including infiltration, nerve block, epidural, and caudal — in a single formulation available in multiple concentrations and vial presentations, as described in the prescribing information.

Warnings:
• Dose-related toxicity: Cardiovascular and respiratory vital signs and patient's state of consciousness must be monitored after injection; delays in managing toxicity may lead to acidosis, cardiac arrest, and death
• Methemoglobinemia: Cases have been reported with local anesthetic use, with potentially severe consequences including seizures, coma, arrhythmias, and death; patients with glucose-6-phosphate dehydrogenase deficiency, infants under 6 months, and those on oxidizing agents are at increased risk
• Risk of systemic toxicities with unintended intravascular or intrathecal injection: May result in CNS or cardiorespiratory depression, coma, and respiratory arrest; aspirate for blood or cerebrospinal fluid prior to each injection and use a test dose for epidural blocks when feasible

Disclaimer: This product description was generated by AI and is for informational purposes only. Please refer to the latest package insert for complete information on indications,
contraindications, warnings, and proper use.

Products specifications
Brands in this category

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.
Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Lidocaine HCl and Epinephrine
Route of Administration Infiltration, Nerve Block
Strength 20 mg/mL
Volume 30 mL
Container Fliptop Multiple Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Local anesthesia

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President